Current best practice for disease activity assessment in IBD

Current best practice for disease activity assessment in IBD

Therapeutic advances in the management of IBD have led to a paradigm shift in the assessment of IBD disease activity. Beyond clinical remission, objective assessment of inflammation is now critical to guiding subsequent therapy as part of a 'treat to target' strategy. Multiple domains of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walsh, A, Bryant, R, Travis, S
Formato:	Journal article
Lenguaje:	English
Publicado:	Nature Publishing Group 2016

Ejemplares similares

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
por: Alex Barnes, et al.
Publicado: (2022-10-01)

Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity
por: Alex Barnes, et al.
Publicado: (2024-01-01)

Is IBD different in the elderly?
por: Travis, S
Publicado: (2008)

IBD and IBS : novel mechanisms and future practice /
por: Falk Symposium (170th : 2009 : Glasgow, Scotland), et al.
Publicado: (c201)

Transitional care in IBD - What is best? Experiences of patients and families
por: Brennan, M, et al.
Publicado: (2007)

Current status of IBD and surgery of Crohn's disease in Thailand
por: Woramin Riansuwan, et al.
Publicado: (2021-09-01)

Is IBD associated with a stressful lifestyle?
por: Dunckley, P, et al.
Publicado: (2008)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Arshdeep Singh, et al.
Publicado: (2023-07-01)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Jessica Mwinyi, et al.
Publicado: (2012-01-01)

Editorial: Current trends and future management of IBD
por: María Manuela Estevinho, et al.
Publicado: (2023-04-01)

Biosimilars in IBD: hope or expectation?
por: Gecse, K, et al.
Publicado: (2013)

Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
por: Gustavo Drügg Hahn, et al.
Publicado: (2022-03-01)

Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
por: Quan-Yao Ban, et al.
Publicado: (2022-06-01)

Nutritional interventions for the treatment of IBD: current evidence and controversies
por: Bénédicte Pigneur, et al.
Publicado: (2019-11-01)

Current best practice in rehabilitation in interstitial lung disease
por: Atsuhito Nakazawa, et al.
Publicado: (2017-02-01)

Development of an index to define overall disease severity in IBD
por: Siegel, C, et al.
Publicado: (2016)

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide
por: F. Scaldaferri, et al.
Publicado: (2017-01-01)

New IBD Markers: Definition of Disease Heterogeneity
por: Stephan R Targan
Publicado: (1995-01-01)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Jihye Park, et al.
Publicado: (2021-09-01)

Intralesional collagenase in the management of Peyronie’s disease: current best practice
por: Daniel J. Cwikla, et al.
Publicado: (2018-04-01)

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
por: Cassinotti, A, et al.
Publicado: (2009)

The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants.
por: van Heel, D, et al.
Publicado: (2003)

Assessing disease activity in patients with ulcerative colitis.
por: Walsh, A, et al.
Publicado: (2012)

IBD and Diet
por: Ilene Gilbert, et al.
Publicado: (1994-01-01)

IBD or strongyloidiasis?
por: Marta Maia Boscá-Watts, et al.

Microbiota and IBD
por: M. Aberg, et al.
Publicado: (2020-06-01)

Microbiota and IBD
por: B. Wu, et al.
Publicado: (2020-01-01)

Novel Small Molecules in IBD: Current State and Future Perspectives
por: André Jefremow, et al.
Publicado: (2023-06-01)

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
por: Benjamin Click, et al.
Publicado: (2022-02-01)

Assessment of Growth Disturbance in Japanese Children with IBD
por: Tetsuo Shono, et al.
Publicado: (2010-01-01)

ANTHROPOMETRIC ASSESSMENT OF OBESITY AMONG IBD PATIENTS
por: Mirela Moneva, et al.
Publicado: (2023-02-01)

IBD: Progress in Pathogenesis
por: Claudio Fiocchi, et al.
Publicado: (1993-01-01)

Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD
por: Oriana M. Damas, et al.
Publicado: (2022-03-01)

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
por: Fabian Schnitzler, et al.
Publicado: (2015-01-01)

Renal trauma: the current best practice
por: Tomer Erlich, et al.
Publicado: (2018-10-01)

Emergency laparoscopy – current best practice
por: Paraskeva Paraskevas, et al.
Publicado: (2006-08-01)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Tyler Atagozli, et al.
Publicado: (2023-04-01)

Validation of the Portuguese Version of IBD-Control Questionnaire and Comparison with IBD-Disk
por: Tânia Carvalho, et al.
Publicado: (2024-10-01)

Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®
por: Jan de Laffolie, et al.
Publicado: (2017-01-01)

Health Literacy of Children and Adolescents with Inflammatory Bowel Disease (IBD) and Parents of IBD Patients—Coping and Information Needs
por: Kalina Kaul, et al.
Publicado: (2024-04-01)